Rachel Moseley is principal academic in psychology at Bournemouth University in the United Kingdom. Her research centers around issues that autistic adults face, including mental ill-health, suicidality, self-injury, aging and late diagnosis. She also investigates aspects of cognition and social communication in autistic people and how these differ depending on personal characteristics, such as sex.
Rachel Moseley
Principal academic
Bournemouth University
From this contributor
Autism and menopause: Q&A with Rachel Moseley and Julie Turner-Cobb
Menopause poses significant challenges for autistic people, according to a small survey published in 2020 — the first to explore the transition among people with autism traits.
Autism and menopause: Q&A with Rachel Moseley and Julie Turner-Cobb
Autism and eating disorders may have an emotional connection
Eating disorders have the highest mortality rates of any kinds of mental illness. They don’t discriminate, affecting people of all ethnicities, sexualities, gender identities, ages and backgrounds.
Autism and eating disorders may have an emotional connection
Explore more from The Transmitter
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.